Key Takeaways
- • Bill Ackman, founder and CEO of Pershing Square Capital Management, is committing $400 million to brain research following his 26-year-old daughter Lucy's near-fatal brain hemorrhage in February 2026.
- • Lucy Ackman was found unconscious in her Brooklyn apartment and underwent emergency surgery at Mount Sinai Hospital in New York 19 hours after the hemorrhage occurred—well beyond the typical five-hour surgical intervention threshold.
- • The newly established institute will focus on neurosurgery, neuroscience, rehabilitation, nutrition, medical device development, human trials, hyperbaric oxygen treatment, and longevity research, structured as an independent Manhattan-based center outside traditional elite universities.
- • Ackman is funding the initiative through a donation of approximately 10 million Pershing Square shares, with his wife Neri Oxman co-contributing to the effort.
Summary
Billionaire investor Bill Ackman announced a $400 million donation to brain research on August 20, 2026, motivated by his daughter Lucy's survival of a catastrophic brain hemorrhage. Lucy, age 26, was discovered unconscious in her Brooklyn apartment in February 2026 and was transported to Mount Sinai Hospital in New York, where she underwent emergency surgery 19 hours after the hemorrhage began. Ackman disclosed that surgical intervention for large brain bleeds is not typically performed if more than five hours have elapsed since the hemorrhagic event, making his daughter's case and survival particularly significant.
The $400 million commitment will establish a neuroscience and longevity research institute headquartered in Manhattan. The facility will operate independently of elite universities, reflecting Ackman's stated concern that traditional academic institutions are losing talent. The institute's research agenda encompasses neurosurgery, neuroscience, rehabilitation protocols, nutritional science, and the development of advanced medical devices. The program will include human clinical trials, hyperbaric oxygen therapy, and broader longevity research initiatives.
Ackman announced the commitment via social media (X), characterizing the donation as both a personal response to his family's medical crisis and a strategic philanthropic investment in neurological science advancement. The funding is being structured through a contribution of approximately 10 million shares in Pershing Square Capital Management, his flagship hedge fund. His wife, Neri Oxman, is participating as a co-contributor to the initiative, underscoring the personal and familial motivation underlying the substantial capital allocation.
The $400 million commitment will establish a neuroscience and longevity research institute headquartered in Manhattan. The facility will operate independently of elite universities, reflecting Ackman's stated concern that traditional academic institutions are losing talent. The institute's research agenda encompasses neurosurgery, neuroscience, rehabilitation protocols, nutritional science, and the development of advanced medical devices. The program will include human clinical trials, hyperbaric oxygen therapy, and broader longevity research initiatives.
Ackman announced the commitment via social media (X), characterizing the donation as both a personal response to his family's medical crisis and a strategic philanthropic investment in neurological science advancement. The funding is being structured through a contribution of approximately 10 million shares in Pershing Square Capital Management, his flagship hedge fund. His wife, Neri Oxman, is participating as a co-contributor to the initiative, underscoring the personal and familial motivation underlying the substantial capital allocation.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.